Pharmacy Times®
Specialty Pharmacy Times
  • Hepatitis C on Track to Become a Rare Disease by 2036
  • FDA Accepts First Application in US for Biosimilar
  • The Updated HIV Prevention Guidelines
  • Study Supports Mammography in Women 75 Years and Older
  • Limited Market for Ebola Vaccine Hinders Development
  • Affordable Care Act Projected to Drive Up Prescription Drug Spending in Coming Years
Aurora Partners with Armada to Deliver Added Pharmacy Capabilities to Specialty Patients
Davy James, Associate Editor
Aurora to utilize enhanced therapy management services with Armada's ReachRx Online Therapy Management system.
Bioethicists: With Limited Supply of Ebola Drugs, Strengthening Health Systems Should Be a Priority
Davy James, Associate Editor
Doctors say experimental drugs should not be limited to well-off patients.
Early Combination Treatment Reduces HIV Viral Load in Infants, But Still Not a Cure
Davy James, Associate Editor
Study finds that ceasing treatment may be the only way to determine if the disease is cured, but doing so carries long-term risks.
Opsumit by Actelion Pharmaceuticals US, Inc
Michael R. Page, PharmD, RPh
Opsumit (macitentan) was approved to reduce the risk of hospitalization and delay disease progression in patients with WHO group I pulmonary arterial hypertension.
Zydelig by Gilead Sciences, Inc
Michael R. Page, PharmD, RPh
The FDA has approved Zydelig (idelalisib) tablets for the later-line treatment of 3 types of cancer, including chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma, and small lymphocytic lymphoma.
Featured Video
The Value of Business Intelligence Software in Specialty Pharmacy
Howard Barsky, chief information officer for Armada Health Care, discusses the benefits of business intelligence software for specialty pharmacies.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 5
Number: 4
Conference Calendar
â—„        August 2014        â–º
Featured Company Profile
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2013
Intellisphere, LLC. All Rights Reserved.